Kidneys From Elderly Deceased Donors-Is 70 the New 60?


Journal

Frontiers in immunology
ISSN: 1664-3224
Titre abrégé: Front Immunol
Pays: Switzerland
ID NLM: 101560960

Informations de publication

Date de publication:
2019
Historique:
received: 05 08 2019
accepted: 04 11 2019
entrez: 13 12 2019
pubmed: 13 12 2019
medline: 11 11 2020
Statut: epublish

Résumé

There is a growing shortage of kidney donors leading to extended transplant waiting times associated with increased mortality. To expand the donor pool, clinicians nowadays regularly accept organs from elderly donors, including those aged ≥70 years. There is only limited and conflicting data whether kidneys from these elderly donors allow for satisfactory allograft outcome rates. To asses this question, the 5-year death censored graft survival of 116,870 adult first deceased donor kidney allograft recipients that were transplanted at European centers between 1997 and 2016 and reported to the "Collaborative Transplant Study" were analyzed using Kaplan-Meier analysis and country stratified Cox regression. The combinations of the two transplant periods 1997-2006 and 2007-2016 with the donor age categories 18-49, 50-59, 60-69, and ≥70 years were considered. From 1997-2006 to 2007-2016, the median donor age increased from 50 to 55 years and the proportion of kidneys from ≥60-year-old donors rose from 24.1 to 38.8%. At the same time, the proportion of kidneys from ≥70-year-old donors more than doubled (6.7 vs. 15.4%). Between 1997-2006 and 2007-2016, the 5-year graft survival improved in all donor age categories. During 2007-2016, the 5-year death censored graft survival of kidneys from ≥70-year-old donors was comparable to that of kidneys from 60 to 69-year-old donors during 1997-2006. This was true both for younger recipients (18-64 years) and older recipients (≥65 years). Among the younger recipients, 45-64-year-old recipients showed the best death censored graft survival rates for kidneys from old donors. In the country-stratified Cox regression analysis, compared to the reference of grafts from 18 to 49-year-old donors, the hazard ratio for grafts from ≥70-year-old donors during 2007-2016 was 1.92, exactly the same as the hazard ratio for grafts from 60 to 69-year-old donors during 1997-2006. Our analysis indicates that within only one further decade (1997-2006 vs. 2007-2016) the 5-year death censored graft survival of kidneys from ≥70-year old donors improved to the level of kidneys from 60 to 69-year-old donors in the previous decade.

Identifiants

pubmed: 31827468
doi: 10.3389/fimmu.2019.02701
pmc: PMC6890834
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2701

Informations de copyright

Copyright © 2019 Echterdiek, Schwenger, Döhler, Latus, Kitterer, Heemann and Süsal.

Références

Transplant Rev (Orlando). 2013 Apr;27(2):43-5
pubmed: 23465693
Am J Transplant. 2010 Apr;10(4 Pt 2):961-72
pubmed: 20420646
Am J Transplant. 2015 Jun;15(6):1623-31
pubmed: 25762442
N Engl J Med. 2002 Feb 21;346(8):580-90
pubmed: 11856798
Am J Transplant. 2017 Dec;17(12):3159-3171
pubmed: 28792681
Adv Chronic Kidney Dis. 2016 Jan;23(1):44-50
pubmed: 26709062
Am J Kidney Dis. 2014 Jan;63(1 Suppl):A7
pubmed: 24360288
Kidney Int. 2018 Nov;94(5):964-973
pubmed: 30049474
Exp Gerontol. 2018 Sep;110:230-240
pubmed: 29935294
Am J Transplant. 2008 Jan;8(1):50-7
pubmed: 17973969
Transpl Int. 2016 Apr;29(4):403-15
pubmed: 26756928
Transplantation. 2009 Mar 27;87(6):795-802
pubmed: 19300179
Transplantation. 2008 Jun 15;85(11):1573-9
pubmed: 18551062
Transplantation. 2009 Jul 27;88(2):231-6
pubmed: 19623019
Nephrol Dial Transplant. 2012 Apr;27(4):1663-71
pubmed: 21926404
Transplantation. 2007 Apr 27;83(8):1069-74
pubmed: 17452897
Lancet. 2017 May 27;389(10084):2152-2162
pubmed: 28561006
Transplantation. 2016 May;100(5):1094-102
pubmed: 26901078
Kidney Int. 2017 Jun;91(6):1287-1299
pubmed: 28320531
Clin J Am Soc Nephrol. 2017 Feb 7;12(2):323-331
pubmed: 27979977
Am J Transplant. 2015 Nov;15(11):2931-9
pubmed: 26108421
Am J Transplant. 2010 Jul;10(7):1613-20
pubmed: 20642686
Am J Kidney Dis. 2008 Sep;52(3):553-86
pubmed: 18725015
BMJ. 2005 Oct 8;331(7520):810
pubmed: 16157605
Transplantation. 2017 Apr;101(4S Suppl 2):S1-S56
pubmed: 28328734
Transplantation. 2007 Jul 27;84(2):137-43
pubmed: 17667803
Lancet. 2011 Oct 15;378(9800):1428-37
pubmed: 22000139
Am J Transplant. 2003;3 Suppl 4:114-25
pubmed: 12694055
Transpl Int. 2016 Mar;29(3):307-14
pubmed: 26565071
Am J Transplant. 2019 Feb;19 Suppl 2:19-123
pubmed: 30811893
Nephrol Dial Transplant. 2010 May;25(5):1680-7
pubmed: 20038521
Transplant Proc. 2004 Sep;36(7):2071-2
pubmed: 15518749

Auteurs

Fabian Echterdiek (F)

Department of Nephrology, Klinikum Stuttgart, Stuttgart, Germany.

Vedat Schwenger (V)

Department of Nephrology, Klinikum Stuttgart, Stuttgart, Germany.

Bernd Döhler (B)

Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Joerg Latus (J)

Department of Nephrology, Klinikum Stuttgart, Stuttgart, Germany.

Daniel Kitterer (D)

Department of Nephrology, Klinikum Stuttgart, Stuttgart, Germany.

Uwe Heemann (U)

Department of Nephrology, Klinikum Rechts der Isar, Technical University Munich, Munich, Germany.

Caner Süsal (C)

Institute of Immunology, Heidelberg University Hospital, Heidelberg, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH